Improving Alzheimer Diagnosis With Innovative Blood-Based
Biomarker Tests and BD-Tau: Mike Miller, PhD
The chief operating officer at Quanterix Corporation talked about pioneering ultra-sensitive blood biomarkers for Alzheimer…














